NTRR Shortlists Targets in Growing Multi-Billion-Dollar Addiction Treatment Industry
NTRR Shortlists Targets in Growing Multi-Billion-Dollar Addiction Treatment Industry
TAMPA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR) announced today that the company is moving forward with plans to deliver innovative new addiction treatments to a hungry marketplace by shortlisting promising targets in the medical technology space.
"Traditional rehabilitation and treatment alone simply aren't getting the results that people demand in the battle against addiction," said NTRR CEO Michael-Shane Henderson. "Medical researchers have responded to this demand, and we could be on the cusp of new game-changing technologies that will soon allow NTRR to offer a more complete approach to addiction recovery."
After shortlisting businesses and researchers that can help NTRR achieve its goals in the marketplace, the company plans to acquire or partner with the organizations nearest to the cutting edge of addiction science.
"Our mission will be putting new tools in the arsenal of the people fighting addiction every day in the country and around the world," Henderson said.
NTRR plans to offer a holistic approach to eliminate addiction cravings in the brain.
For more information on NTRR's efforts to market effective remedies for common afflictions, please visit www.neutracorp.com/investors.html.
Follow NTRR on Twitter at www.twitter.com/neutracorp.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Michael-Shane Henderson, 713-821-1486
President and CEO
info@neutracorp.com
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS:
The article NTRR Shortlists Targets in Growing Multi-Billion-Dollar Addiction Treatment Industry originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
